EUVIMEDOpdag EUVIMED
Open access · CC BY 4.0

Residue-Level Determination of Small-Molecule–Protein Affinities by Hydrogen–Deuterium Exchange Mass Spectrometry

De Lin, Luma Godoy Magalhaes, Joel McMillan, Thomas C Eadsforth, Greg Stewart, Kieran R Cartmill, Vincent L G Postis, Glenn R Masson iD

Journal of the American Society for Mass Spectrometry · 2026

DOI: 10.1021/jasms.6c00020 ↗

At a glance

Journal article in Journal of the American Society for Mass Spectrometry, 2026. Written by De Lin and 7 co-authors. Institution: Drug Discovery Unit, Division of Biological Chemistry and Drug Discovery, School of Life Science, University of Dundee, Dundee DD1 5EH, U.K. Major MEDLINE topics: Hydrogen Deuterium Exchange-Mass Spectrometry, Proteins. Cited 1 times so far (Crossref); 46 references. The full text is freely available (open access, CC BY 4.0). Funded by: University of Dundee, Wellcome Trust, Biotechnology and Biological Sciences Research Council.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Hydrogen-Deuterium Exchange Mass Spectrometry (HDX-MS) is an established tool in drug discovery, used to characterize target engagement and conformational dynamics, and frequently used in both biopharmaceutical and small molecule drug discovery. Conventional HDX-MS experiments are performed at saturating ligand concentrations to generate a binding "footprint", where decreased solvent exchange reflects a local structural stabilization or reduced solvent accessibility upon binding. Here, we present an extended HDX-MS and HDX-MS/MS titration workflow with electron capture dissociation (ECD) fragmentation capable of estimating apparent dissociation constants (KDapp) at global, peptide, and single amino acid resolution by fitting uptake-concentration relationships under EX2 exchange and Langmuir binding assumptions. The ability to determine affinity constants in a spatially resolved manner combined with the automation available in HDX-MS sample handling and data analysis enables quantitative mapping of ligand-protein interactions and provides a scalable approach for structure-activity relationship studies in drug discovery.

Subjects

MeSH terms (MEDLINE)

Hydrogen Deuterium Exchange-Mass SpectrometryProteinsLigandsProtein BindingTandem Mass SpectrometryPeptidesDeuterium Exchange Measurement

Author keywords

HDX-MSHDX-MS/MShydrogen Isotopesionsligandsmass spectrometrypeptides and proteins

Substances

ProteinsLigandsPeptides

Authors and institutions

  • Drug Discovery Unit, Division of Biological Chemistry and Drug Discovery, School of Life Science, University of Dundee, Dundee DD1 5EH, U.K.
  • Division of Cancer Research, School of Medicine, University of Dundee, Dundee DD1 9SY, U.K.

ORCID profiles: Glenn R Masson

Funding

  • University of Dundee
  • Wellcome Trust
  • Biotechnology and Biological Sciences Research Council

Cite

APA

Lin, Magalhaes, L. G., McMillan, J., Eadsforth, T. C., Stewart, G., Cartmill, K. R., Postis, V. L. G., & Masson, G. R. (2026). Residue-Level Determination of Small-Molecule–Protein Affinities by Hydrogen–Deuterium Exchange Mass Spectrometry. Journal of the American Society for Mass Spectrometry. https://doi.org/10.1021/jasms.6c00020

Vancouver

Lin, Magalhaes LG, McMillan J, Eadsforth TC, Stewart G, Cartmill KR, et al. Residue-Level Determination of Small-Molecule–Protein Affinities by Hydrogen–Deuterium Exchange Mass Spectrometry. Journal of the American Society for Mass Spectrometry. 2026. doi:10.1021/jasms.6c00020

BibTeX
@article{Lin2026,
  author = {Lin, De and Magalhaes, Luma Godoy and McMillan, Joel and Eadsforth, Thomas C and Stewart, Greg and Cartmill, Kieran R and Postis, Vincent L G and Masson, Glenn R},
  title = {Residue-Level Determination of Small-Molecule–Protein Affinities by Hydrogen–Deuterium Exchange Mass Spectrometry},
  journal = {Journal of the American Society for Mass Spectrometry},
  year = {2026},
  doi = {10.1021/jasms.6c00020}
}
Start for free →